Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02803242 · ClinicalTrials.gov registry record
COPD Patient-Powered Research Network
A clinical trial of Emphysema and Chronic Bronchitis, sponsored by COPD Foundation.
- Recruiting
- Registry status
- 75,000
- Enrollment target
- 1
- Study location
NCT02803242 is a study of Emphysema and Chronic Bronchitis that is actively recruiting participants, run by COPD Foundation. The registered enrollment target is 75,000 participants, above the 803-participant average among 25 other Emphysema trials with a reported enrollment target (9240% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02803242, a study of Emphysema and Chronic Bronchitis, is actively recruiting participants, sponsored by COPD Foundation.
- RECRUITING
- Registry status
- 75,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they qualify for and become connected to COPD resources. The goal of the registry is to speed research to find better treatments for COPD and ultimately a cure.
Conditions Studied
Interventions
- OTHER Patient Reported Outcomes
Study Locations (1)
District of Columbia
- COPD Foundation - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75,000 participants |
| Start Date | 2014-08 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02803242
The ClinicalTrials.gov registry entry for NCT02803242 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 803-participant average among 25 other Emphysema trials with a reported enrollment target (9240% higher). The listed sponsor is COPD Foundation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Emphysema appearing as the primary indexed condition, and to 1 intervention - of which Patient Reported Outcomes is the first listed.
NCT02803242 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02803242 about?
NCT02803242 is a clinical study titled "COPD Patient-Powered Research Network". The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform t...
What is the current status of trial NCT02803242?
This trial is currently recruiting. The enrollment target is 75,000 participants. The study started on 2014-08. Estimated completion is 2030-01.
What conditions does trial NCT02803242 study?
This clinical trial studies the following conditions: Emphysema, Chronic Bronchitis, Chronic Obstructive Pulmonary Disorder, Chronic Obstructive Lung Disease.
What interventions are being tested in trial NCT02803242?
The interventions under investigation include: Patient Reported Outcomes (OTHER).
Who is sponsoring clinical trial NCT02803242?
This trial is sponsored by COPD Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02803242 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emphysema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
RECRUITING
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
RECRUITING · Phase 2
-
Biological Effects of Quercetin in COPD Phase II
RECRUITING · Phase 2
-
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
RECRUITING · NA
-
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
RECRUITING · NA
-
STRIVE Post-Market Registry Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.